CAN J CARDIOL 润色咨询

CANADIAN JOURNAL OF CARDIOLOGY

出版年份：1985 年文章数：1537 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：10.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2019-11-16 努力的科研小白

    接收综述吗？需要版面费吗？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2023-01-28 ms6000001445187607 来自陕西省

    这个期刊一作可以有几位？可以共一吗？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2021-12-28 小动量

    讨论中我和之前发表文章结果不一致怎么处理？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2021-12-28 Mia

    讨论中一般可以讨论什么？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2021-12-22 ms5000000444908658

    朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2021-07-27 cacojin

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：编辑非常效率，几天拒稿

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2020-01-02 misssheng

    这个杂志只收临床的文章吗？还是偏重临床？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2019-08-02 ms9285292773773234

    一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2019-05-24 happensky

    审稿速度:1.0
    经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。
    两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571427, encodeId=06c05e142743, content=审稿速度:1.0<br>经验分享：4.19投稿，5.16一审返回；5.20修回，5.24 accept。 <br> 两个审稿人提了一些非常简单问题，基本上算是没有提什么问题；这可能与我前期投稿IJC及AJC，一共8个审稿人炮轰了一遍，然后我仔细修改了有关；另外一个杂志（European Radiology），我真心感谢那个审稿人，我用同样数据库写的另外一篇文章投过去/虽然拒稿了，但其中一个审稿人审稿非常细，把很多问题提出来，非常nice，我也在这个文章中做了修改。所以，反复投稿，大牌杂志大多数的审稿意见还是比较好的，结合着修改，对文章提升肯定有帮助。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTI9X140JXPuaFlkbic5sARsBSMUgnrib38Tm3KQxGTerMicVAmmiaxAEkjLsgd6icY95jeUEzSiaHAuM9Bw/132, createdBy=d66612701, createdName=happensky, createdTime=Fri May 24 11:32:00 CST 2019, time=2019-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=567155, encodeId=603756e15523, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：11-02投稿 <br> 12-21第一轮（小修） <br> 1-13修回 <br> 2-13 第二轮（小修） <br> 2-20修回 <br> 2-21接收 <br> 第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/9579f020230e4edc53ddbb1bf6fa43ca/834c036a3f6c9d13568741937c3e1046.jpg, createdBy=328a1666759, createdName=DrBruins, createdTime=Sat Feb 23 15:33:00 CST 2019, time=2019-02-23, status=1, ipAttribution=)]
    2019-02-23 DrBruins

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：11-02投稿
    12-21第一轮（小修）
    1-13修回
    2-13 第二轮（小修）
    2-20修回
    2-21接收
    第二次投这个刊物，过程比较顺利，编辑很nice，不会刁难，评审的意见非常中肯，revision的时候一定要尽力找支持自己的证据，因为评审意见里真的会引用一些比较新的文献里的观点来质疑你。

    0

共33条页码: 1/4页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分